Preventing postpartum diabetes in women with gestational diabetes
Official title: Gestational Diabetes - A Randomized, Controlled Trial PrEvention of PostPartum Diabetes Study (the PEPP Diabetes Study)
Run by Vastra Gotaland Region · NCT05112588 · Data updated 2026-11-12
This study is testing whether special support and encouragement can help women who had gestational diabetes avoid developing type 2 diabetes after giving birth.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | Women only |
| Enrollment | 600 (estimated) |
| Sponsor | Vastra Gotaland Region Government |
| Locations | 1 site (Skövde) |
| Status | Recruiting |
| Started | November 1, 2021 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2030 |
| Registry record updated | June 13, 2024 |
| Trial ID | NCT05112588 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are women who have been diagnosed with gestational diabetes and are willing to participate in follow-up care.
✕Probably not a fit
Patients with pre-existing diabetes or other endocrine disorders that affect blood glucose control may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study focuses on women diagnosed with gestational diabetes, aiming to prevent the development of type 2 diabetes postpartum. It involves a randomized clinical approach where participants will receive interventions designed to promote physical activity and adherence to follow-up care. The study addresses the challenges faced by women post-delivery, including the lack of compliance with glucose tolerance testing and follow-up recommendations. By implementing new diagnostic criteria and support systems, the study seeks to improve health outcomes for both mothers and their children.
Why it matters
Potential benefit: If successful, this study could significantly reduce the risk of type 2 diabetes in women who have experienced gestational diabetes.
How similar studies have gone: Other studies have shown success in similar approaches to managing gestational diabetes and preventing postpartum diabetes, indicating potential for positive outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Gestational diabetes * Signed "Informed consent" * Will be expected to participate in ordinary child health care. * Access to Internet via computer, pad or phone Exclusion Criteria: * Manifest diabetes mellitus before pregnancy. * Other conditions, e.g. endocrine disorders, or treatment, e.g. cortisone medication, that could affect blood glucose control * Suspicion of type 1 diabetes mellitus as assessed by GAD antibodies or clinical history * Participation in other concomitant research study that could interfere with the study parameters * Other disease, treatment or condition that according to the Principal Investigator precludes participation
Where it's running
-
Maternity Ward, Västra Götaland
Skövde, Sweden Recruiting
Study contacts
- Principal investigator: Margareta MI Hellgren — Vastra Gotaland
- Study coordinator: Margareta I Hellgren
- Email: margareta.leonardsson-hellgren@vgregion.se
- Phone: +46708381612
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Early Glucose Patterns in Pregnant Women at Risk for GDM
This study tests whether continuous glucose monitoring in early pregnancy can detect dysglycemia before GDM is diagnosed, in women with and without known risk factors.
-
Probiotic-augmented therapy for gestational diabetes
This trial tests whether adding multistrain probiotics to metformin, insulin, or their combination can improve blood sugar control and inflammation in pregnant women with gestational diabetes.
-
Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes
This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.
-
How sleep, lifestyle, and metabolism relate to pregnancy outcomes in gestational diabetes
This project will see if sleep quality, anxiety, eating and activity habits, and metabolic markers relate to blood sugar control and birth outcomes in pregnant people with gestational diabetes.
-
Pre-eclampsia risk in pregnancies after oocyte donation
We will follow pregnant women who used donated eggs and women who used their own eggs to see if pregnancies after oocyte donation lead to a higher risk of pre-eclampsia.
-
Mobile-based obstetric monitoring for hypertension and diabetes during pregnancy
A mobile app-based program lets pregnant people with high blood pressure or gestational diabetes track BP and glucose at home and share results with their care team to guide care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.